GSA Capital Partners’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100,319
| Closed | -$190K | – | 1967 |
|
|
2024
Q4 | $190K | Buy |
+100,319
| New | +$190K | 0.01% | 1428 |
|
|
2023
Q4 | – | Sell |
-12,970
| Closed | -$57K | – | 1805 |
|
|
2023
Q3 | $57K | Buy |
+12,970
| New | +$57K | ﹤0.01% | 1412 |
|
|
2023
Q2 | – | Sell |
-4,892
| Closed | -$107K | – | 1830 |
|
|
2023
Q1 | $107K | Sell |
4,892
-8,997
| -65% | -$197K | 0.01% | 1349 |
|
|
2022
Q4 | $300K | Buy |
13,889
+5,498
| +66% | +$119K | 0.04% | 932 |
|
|
2022
Q3 | $205K | Buy |
8,391
+140
| +2% | +$3.42K | 0.03% | 1212 |
|
|
2022
Q2 | $168K | Sell |
8,251
-4,559
| -36% | -$92.8K | 0.03% | 1115 |
|
|
2022
Q1 | $456K | Buy |
12,810
+2,308
| +22% | +$82.2K | 0.06% | 598 |
|
|
2021
Q4 | $286K | Buy |
+10,502
| New | +$286K | 0.04% | 964 |
|